04 February
Global pharma company Jazz Pharmaceuticals has reached an agreement to buy United Kingdom-based GW Pharmaceuticals, one of the largest medical cannabinoid businesses in the world, for $7.2 billion in cash and stock, the drugmakers announced Wednesday. The proposed transaction would be the largest move to date by a pharma company into cannabis, demonstrating that pharmaceutical […]
Read More